The efficacy of screening with FDG-PET/CT for distant metastases in breast cancer patients scheduled for neoadjuvant systemic therapy
The results of the current study support the routine use of FDG-PET/CT for the detection of distant metastases in breast cancer patients with initial clinical stage 2b and 3, regardless of tumor subtype.
Authors
- Astrid N. Scholten (ORCID: https://orcid.org/0000-0002-3242-4989)
- A. Marjolein Schrijver (ORCID: https://orcid.org/0000-0002-2260-3983)
- Corrie A.M. Marijnen (ORCID: https://orcid.org/0000-0003-0189-5953)
- Vincent O. Dezentjé (ORCID: https://orcid.org/0000-0001-7650-8407)
- Jetske L B Gunster (ORCID: https://orcid.org/0000-0002-9287-8181)
- Marcel P. M. Stokkel (ORCID: https://orcid.org/0000-0002-8131-5690)
- Carolien H. Smorenburg (ORCID: https://orcid.org/0000-0002-1046-2634)
- Claudette E. Loo (ORCID: https://orcid.org/0000-0001-8155-7051)
- Josefien P. van Olmen (ORCID: https://orcid.org/0000-0001-6971-2688)
- Frederieke van Duijnhoven (ORCID: https://orcid.org/0000-0003-3694-4049)
Institutions
- Leiden University Medical Center (NL)
- The Netherlands Cancer Institute (NL)
- Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NL)
Publication Details
- Journal
- Breast Cancer Research and Treatment
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1007/s10549-024-07478-5
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00